SEC Comment Letter for TAURIGA SCIENCES, INC. (CIK 0001142790) — Mar 11, 2020
TAURIGA SCIENCES, INC. (CIK 0001142790)
Date: March 11, 2020 · CIK: 0001142790 · Accession: 0000000000-20-002177
AI Filing Summary & Sentiment
File numbers found in text: 333-236923
Letter
March 11, 2020 Seth M. Shaw Chief Executive Officer Tauriga Sciences, Inc. 555 Madison Avenue, 5th Floor New York, NY 10022 Re:Tauriga Sciences, Inc. Registration Statement on Form S-1 Filed March 5, 2020 File No. 333-236923 Dear Mr. Shaw: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Theodore Ghorra - Rimon Law P.C.
Show Raw Text
March 11, 2020
Seth M. Shaw
Chief Executive Officer
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Re:Tauriga Sciences, Inc.
Registration Statement on Form S-1
Filed March 5, 2020
File No. 333-236923
Dear Mr. Shaw:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Theodore Ghorra - Rimon Law P.C.